Sirolimus for treatment of kaposiform hemangioendothelioma associated with Kasabach-Merritt phenomenon.
about
Sirolimus for treatment of kaposiform hemangioendothelioma associated with Kasabach-Merritt phenomenon.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Sirolimus for treatment of kap ...... h Kasabach-Merritt phenomenon.
@en
Sirolimus for treatment of kap ...... h Kasabach-Merritt phenomenon.
@nl
type
label
Sirolimus for treatment of kap ...... h Kasabach-Merritt phenomenon.
@en
Sirolimus for treatment of kap ...... h Kasabach-Merritt phenomenon.
@nl
prefLabel
Sirolimus for treatment of kap ...... h Kasabach-Merritt phenomenon.
@en
Sirolimus for treatment of kap ...... h Kasabach-Merritt phenomenon.
@nl
P2093
P2860
P1433
P1476
Sirolimus for treatment of kap ...... h Kasabach-Merritt phenomenon.
@en
P2093
Alaa M Alaqeel
Alanoud A Alhedyani
Nuha A Alfurayh
Saad M Alajlan
P2860
P304
P356
10.1016/J.JDCR.2016.06.005
P577
2016-11-01T00:00:00Z